PRISCILLA SELIG: Open Payments
NPI 1447860374 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 42 payments from 13 companies in 2025. Trend: 2023 $951 · 2024 $822 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $207 |
| AstraZeneca Pharmaceuticals LP | 5 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $83 |
| Novo Nordisk Inc | 3 | $69 |
| ALK-Abello, Inc | 3 | $65 |
| PFIZER INC. | 3 | $58 |
| Lilly USA, LLC | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Amgen Inc. | 2 | $32 |
Products named: VRAYLAR, CAPLYTA, AIRSUPRA, FARXIGA, QULIPTA, MOUNJARO, FANAPT, REPATHA.
Industry payments across FL — which companies pay providers there.
